Adverse events after pars plana vitrectomy among medicare beneficiaries

Archives of Ophthalmology

Volumn 127, Issue 12, 2009, Pages 1656-1663

  Stein, Joshua D ^a   Zacks, David N ^a   Grossman, Daniel ^b   Grabe, Hilary ^a   Johnson, Mark W ^a   Sloan, Frank A ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; BLINDNESS; CHOROID DETACHMENT; CHOROID HEMORRHAGE; CILIARY DISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORNEA EDEMA; CORNEA EROSION; DEMOGRAPHY; DISEASE SEVERITY; ENDOPHTHALMITIS; EUROPEAN AMERICAN; FEMALE; GLAUCOMA; HUMAN; INCIDENCE; INTRAOCULAR HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RETINA DETACHMENT; RETINA EDEMA; RETINA TEAR; REVIEW; UNITED STATES; VITRECTOMY; VITREOUS HEMORRHAGE; ARTICLE; HEALTH SERVICES RESEARCH; PROPORTIONAL HAZARDS MODEL; STATISTICS;

AGED; AGED, 80 AND OVER; CHOROID HEMORRHAGE; ENDOPHTHALMITIS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; MALE; MEDICARE; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETINAL DETACHMENT; UNITED STATES; VITRECTOMY;

EID: 73349084328     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.300     Document Type: Review

References (54)

1. Machemer R. The development of pars plana vitrectomy: a personal account. Graefes Arch Clin Exp Ophthalmol. 1995;233(8):453-468.
2. Fujii GY, De Juan E Jr, Humayun MS, et al. Initial experience using the trans-conjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002;109(10):1814-1820.
3. Fujii GY, De Juan E Jr, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002; 109(10):1807-1813.
4. Acar N, Unver YB, Altan T, Kapran Z. Acute endophthalmitis after 25-gauge sutureless vitrectomy. Int Ophthalmol. 2007;27(6):361-363.
5. Byeon SH, Chu YK, Lee SC, Koh HJ, Kim SS, Kwon OW. Problems associated with the 25-gauge transconjunctival sutureless vitrectomy system during and after surgery. Ophthalmologica. 2006;220(4):259-265.
6. Kunimoto DY, Kaiser RS; Wills Eye Retina Service. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology. 2007;114(12):2133-2137.
7. Kusuhara S, Ooto S, Kimura D, et al. Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes. Br J Ophthalmol. 2008;92(9):1261-1264.
8. Scott IU, Flynn HW Jr, Dev S, et al. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina. 2008;28(1): 138-142.
9. Williams GA. 25-, 23-, or 20-gauge instrumentation for vitreous surgery? Eye. 2008;22(10):1263-1266.
10. Ahmadieh H, Moradian S, Faghihi H, et al; Pseudophakic and Aphakic Retinal Detachment (PARD) Study Group. Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation, report No. 1. Ophthalmology. 2005;112(8):1421-1429.
11. Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention. Ophthalmology. 2008;115(12):2215-2220.
12. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9), Clinical Modification. Geneva, Switzerland: World Health Organization; 1977.
13. American Medical Association. Current Procedural Terminology: CPT 2005 Standard Edition. Chicago, IL: American Medical Association; 2005.
14. Blankenship GW. Endophthalmitis after pars plana vitrectomy. Am J Ophthalmol. 1977;84(6):815-817.
15. Kattan HM, Flynn HW Jr, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology. 1991;98(2):227-238.
16. Bacon AS, Davison CR, Patel BC, Frazer DG, Ficker LA, Dart JK. Infective endophthalmitis following vitreoretinal surgery. Eye. 1993;7(pt 4):529-534.
17. Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE; The Postvitrectomy Endophthalmitis Study Group. Endophthalmitis after pars plana vitrectomy. Ophthalmology. 1995;102(5):705-712.
18. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology. 1995;102(5):775-781.
19. Aaberg TM Jr, FlynnHWJr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105(6):1004-1010.
20. Campo RV, Sipperley JO, Sneed SR, et al. Pars plana vitrectomy without scleral buckle for pseudophakic retinal detachments. Ophthalmology. 1999;106(9): 1811-1816.
21. Eifrig CW, Scott IU, Flynn HW Jr, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138(5):799-802.
22. Brazitikos PD, Androudi S, Christen WG, Stangos NT. Primary pars plana vitrectomy versus scleral buckle surgery for the treatment of pseudophakic retinal detachment: a randomized clinical trial. Retina. 2005;25(8):957-964.
23. Ibarra MS, Hermel M, Prenner JL, Hassan TS. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol. 2005;139(5): 831-836.
24. Joondeph BC, Blanc JP, Polkinghorne PJ. Endophthalmitis after pars plana vitrectomy: a New Zealand experience. Retina. 2005;25(5):587-589.
25. Lakhanpal RR, Humayun MS, de Juan E Jr, et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology. 2005;112(5):817-824.
26. Oshima Y, Ohji M, Tano Y. Surgical outcomes of 25-gauge transconjunctival vitrectomy combined with cataract surgery for vitreoretinal diseases. Ann Acad Med Singapore. 2006;35(3):175-180.
27. Weichel ED, Martidis A, Fineman MS, et al. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology. 2006;113(11):2033-2040.
28. Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers RD, Foerster MH; Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment Study Group. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study. Ophthalmology. 2007;114(12):2142-2154.
29. Kim MJ, Park KH, Hwang JM, Yu HG, Yu YS, Chung H. The safety and efficacy of transconjunctival sutureless 23-gauge vitrectomy. Korean J Ophthalmol. 2007; 21(4):201-207.
30. Valmaggia C. Pars plana vitrectomy with 25-gauge instruments in the treatment of idiopathic epiretinal membranes. Klin Monatsbl Augenheilkd. 2007;224(4): 292-296.
31. Yamakiri K, Sakamoto T, Noda Y, et al. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology. 2007;114(2):289-296.
32. Chen JK, Khurana RN, Nguyen QD, Do DV. The incidence of endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy. Eye. 2009; 23(4):780-784.
33. Gupta OP, Ho AC, Kaiser PK, et al. Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2008;146(2):193-197.
34. Guyomarch J, Delyfer MN, Korobelnik JF. Outcomes of 110 consecutive 25-gauge transconjunctival sutureless pars plana vitrectomies [in French]. J Fr Ophtalmol. 2008;31(5):473-480.
35. Lai MM, Ruby AJ, Sarrafizadeh R, et al. Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy. Retina. 2008;28(5):729-734.
36. Lommatzsch A, Heimes B, Trieschmann M, Spital G, Pauleikhoff D. Long-term results after pars plana vitrectomy with 25 gauge technique [in German]. Ophthalmologe. 2008;105(5):445-451.
37. Mason JO III, Yunker JJ, Vail RS, et al. Incidence of endophthalmitis following 20-gauge and 25-gauge vitrectomy. Retina. 2008;28(9):1352-1354.
38. Miller DM, Riemann CD, Foster RE, Petersen MR. Primary repair of retinal detachment with 25-gauge pars plana vitrectomy. Retina. 2008;28(7):931-936.
39. Mollan SP, Mollan AJ, Konstantinos C, Durrani OM, Butler L. Incidence of endophthalmitis following vitreoretinal surgery. Int Ophthalmol. 2009;29(3):203-205.
40. Tewari A, Shah GK, Fang A. Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy. Retina. 2008;28(2):258-262.
41. Wimpissinger B, Kellner L, Brannath W, et al. 23-Gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol. 2008;92(11):1483-1487.
42. Practice Trends and Surveys, American Society of Retina Specialists. http://www .asrs.org. Accessed January 2, 2009.
43. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113(3):325-332.
44. Shea AM, Curtis LH, Hammill BG, et al. Resource use and costs associated with diabetic macular edema in elderly persons. Arch Ophthalmol. 2008;126(12): 1748-1754.
45. Heier JS, Boyer DS, Ciulla TA, et al; FOCUS Study Group. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol. 2006; 124(11):1532-1542.
46. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001;131(4):468-471.
47. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol. 2003;87(4):462-468.
48. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, et al; Pan American Collaborative Retina Group (PACORES). Twelve-month safety of intravitreal injections of bevacizumab (Avastin(R)): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol. 2008;246(1): 81-87.
49. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118(3):338-342.
50. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112(8):1388-1394.
51. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction: endophthalmitis following inpatient surgery. Arch Ophthalmol. 1991;109(8): 1085-1089.
52. Stein JD, Ruiz D Jr, Belsky D, Lee PP, Sloan FA. Longitudinal rates of post-operative adverse outcomes after glaucoma surgery among Medicare beneficiaries 1994 to 2005. Ophthalmology. 2008;115(7):1109-1116, e7.
53. Coleman AL, Morgenstern H. Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery. Surv Ophthalmol. 1997;42(3):271-278.
54. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003;121(9):1303-1310.